These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 33979703)

  • 1. How the European in vitro diagnostic regulation could negatively impact the European response to the next pandemic: an urgent call for action before May 2022.
    Vermeersch P; André E
    Clin Microbiol Infect; 2021 Aug; 27(8):1074-1075. PubMed ID: 33979703
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical Device Regulation: A Comparison of the United States and the European Union.
    Maak TG; Wylie JD
    J Am Acad Orthop Surg; 2016 Aug; 24(8):537-43. PubMed ID: 27195383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex analytical procedures in diagnostic laboratories and the IVDR.
    Vogeser M; Brüggemann M
    Clin Chem Lab Med; 2020 Dec; 59(3):457-458. PubMed ID: 33554564
    [No Abstract]   [Full Text] [Related]  

  • 4. Easing Medical Device Regulatory Oversight: The FDA and Testing Amidst the COVID-19 Pandemic.
    Maxwell K
    Am J Law Med; 2021 Jul; 47(2-3):291-326. PubMed ID: 34405782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary: Europe needs a central, transparent, and evidence based regulation process for devices.
    Eikermann M; Gluud C; Perleth M; Wild C; Sauerland S; Gutierrez-Ibarluzea I; Antoine SL; Demotes-Mainard J; Neugebauer EA;
    BMJ; 2013 May; 346():f2771. PubMed ID: 23653340
    [No Abstract]   [Full Text] [Related]  

  • 6. Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: Guidance is urgently required for haemostasis testing.
    Testa S; Meijer P; Lasne D; Mullier F
    Int J Lab Hematol; 2022 Sep; 44 Suppl 1():71-78. PubMed ID: 36074714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles of ideal diagnostic regulation and the IVDR.
    Hallersten AM; Decker NM; Huang Y
    Clin Chem Lab Med; 2023 Mar; 61(4):599-607. PubMed ID: 36544267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could expanding the covid-19 case definition improve the UK's pandemic response?
    Crozier A; Dunning J; Rajan S; Semple MG; Buchan IE
    BMJ; 2021 Jun; 374():n1625. PubMed ID: 34193527
    [No Abstract]   [Full Text] [Related]  

  • 9. Implementing the EU in vitro diagnostic regulation - a European regulatory perspective on companion diagnostics.
    Ritzhaupt A; Hayes I; Ehmann F
    Expert Rev Mol Diagn; 2020 Jun; 20(6):565-567. PubMed ID: 31976775
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful implementation of SARS-CoV-2 testing in midst of pandemic with emphasis on all phases of testing.
    Petersen JM; Dalal S; Jhala D
    J Clin Pathol; 2021 May; 74(5):273-278. PubMed ID: 33731334
    [No Abstract]   [Full Text] [Related]  

  • 11. The new IVD Regulation 2017/746: a case study at a large university hospital laboratory in Belgium demonstrates the need for clarification on the degrees of freedom laboratories have to use lab-developed tests to improve patient care.
    Vermeersch P; Van Aelst T; Dequeker EMC
    Clin Chem Lab Med; 2020 Jul; 59(1):101-106. PubMed ID: 32692695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 testing and infection control strategies in European paediatric emergency departments during the first wave of the pandemic.
    Kohns Vasconcelos M; Renk H; Popielska J; Nyirenda Nyang'wa M; Burokiene S; Gkentzi D; Gowin E; Donà D; Villanueva-Medina S; Riordan A; Hufnagel M; Eisen S; Da Dalt L; Giaquinto C; Bielicki JA
    Eur J Pediatr; 2021 Apr; 180(4):1299-1305. PubMed ID: 33051714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications.
    Bank PCD; Jacobs LHJ; van den Berg SAA; van Deutekom HWM; Hamann D; Molenkamp R; Ruivenkamp CAL; Swen JJ; Tops BBJ; Wamelink MMC; Wessels E; Oosterhuis WP
    Clin Chem Lab Med; 2020 Nov; ():. PubMed ID: 33554568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the safety and effectiveness of novel personal protective equipment during the COVID-19 pandemic.
    Desselle MR; Kirrane M; Chao IT; Coles Black J; Woodruff MA; Chuen J; Sullivan C
    Med J Aust; 2021 Jun; 214(11):496-499.e1. PubMed ID: 34046903
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of medical device regulation on hospital doctors who prescribe and manufacture custom-made devices.
    Green JI
    Br J Hosp Med (Lond); 2020 Dec; 81(12):1-6. PubMed ID: 33377827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro medical devices: how businesses can successfully comply with the new European regulation.
    Moan B; Rabin N
    Ann Biol Clin (Paris); 2018 Dec; 76(6):716-718. PubMed ID: 30270823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Petition of European experts on medical products legislation].
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(4-5):347-50. PubMed ID: 24066377
    [No Abstract]   [Full Text] [Related]  

  • 18. A Proposed COVID-19 Testing Algorithm.
    Hart A; Bortolin M; Awoniyi O; Alhajjaj F; Ciottone GR
    Disaster Med Public Health Prep; 2020 Oct; 14(5):e11-e15. PubMed ID: 32576313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catching up on medical device safety.
    The Lancet Oncology
    Lancet Oncol; 2019 Jan; 20(1):1. PubMed ID: 30614458
    [No Abstract]   [Full Text] [Related]  

  • 20. A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe.
    Campillo-Artero C
    Health Policy; 2013 Nov; 113(1-2):38-44. PubMed ID: 23602548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.